AzTrials
AzTrials

Neck Pain MusculoskeletalPhase 2/3IbedriftNCT00741650

Ibedrift- A Trial Comparing a New Approach to Musculoskeletal Pain Consisting of Education and Peer Involvement to Treatment as Usual

A Phase 2/3 study testing Information and Peer advisor and Information, peer advisor and fast referral in people with Neck Pain Musculoskeletal and Back Pain Lower Back, run by NORCE Norwegian Research Centre AS at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A randomized controlled trial comparing a new approach to musculoskeletal pain consisting of education and peer involvement to treatment as usual. All local government employees in 1-3 Norwegian municipalities will be invited to participate. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Information and Peer advisor and Information, peer advisor and fast referral
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,097 participants
Where
1 siteNorway
Study dates
Sep 2008to Dec 2012
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • All employees above 18 years

Who cannot join

  • Cancer
  • Known congenital musculoskeletal disease
  • Cauda equina syndrome

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Spesialsykehuset for Rehabilitering

    Stavern, 3294

Other trials in Norway

About this study

Official title: Ibedrift- Health Related Coping. A Randomized Controlled Trial Comparing a Worksite Educational Intervention With or Without Referral to Treatment as Usual.

A randomized controlled trial comparing a new approach to musculoskeletal pain consisting of education and peer involvement to treatment as usual. All local government employees in 1-3 Norwegian municipalities will be invited to participate.

Read the detailed description

The purpose of the study is to systematically test a new treatment method for musculoskeletal pain in Norway. The intervention focuses on attempting to treat musculoskeletal pain outside the traditional medical system as much as possible, to avoid the establishment of a patient identity and passive patient behavior. In addition, participants are given reasons to stay active, and not advice to stay active.

Ibedrift is a randomized controlled trial with the aim of studying the effect of a new treatment regime for musculoskeletal pain, focusing on didactic information about low back pain with peer support. Those participants not in the control group will have the option of contacting a peer advisor, a non health professional trained by the iBedrift crew to give information about back pain and reasons to stay active. For those who have not recovered within a short period of time, and who are randomized to full treatment, the peer advisor can send them directly to health personnel for a brief intervention consisting of a medical examination with screening for conditions that need treatment, counseling and education.

The intervention was done in 2 Norwegian municipalities for all local government employees. Randomization was done at the level of working units (schools, offices etc) which allows for more message containment.

Being tested
Information and Peer advisor, Information, peer advisor and fast referral
Keywords
Musculoskeletal pain, Brief cognitive intervention, Cognitive behavior therapy, Intervention Study, Health prevention, workplace intervention
Medical subject headings
Low Back Pain, Musculoskeletal Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Information and Peer advisorBehavioural

    Information at work place and recruitment and training of one employee as a peer advisor who help colleagues who experience musculoskeletal pain with reasons to stay active, help with adjustment in the work situation to allow individuals to stay at work.

  • Information, peer advisor and fast referralBehavioural

    Information at work place and recruitment and training of one employee as a peer advisor who help colleagues who experience musculoskeletal pain with reasons to stay active, help with adjustment in the work situation to allow individuals to stay at work.

    In addition, the peer advisor can refer employees who do not improve to a two day educational program that also includes a medical exam and individual counselling.

    In addition,

Study groups in NCT00741650
Study groupRoleWhat they receive
1ExperimentalInformation and peer advisor
Receives: Behavioral: Information and Peer advisor
2ExperimentalInformation, peer advisor and referral to further treatment
Receives: Behavioral: Information, peer advisor and fast referral
3No interventionTreatment as usual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sick Leave

    Measured: 1 year and 2 year after start of intervention

Secondary outcomes (2)
  1. Low Back pain

    Measured: 1 year and 2 years after intervention

  2. Subjective Health complaints

    Measured: 1 year and 2 years after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2008 (estimated)
  2. Study startSep 2008
  3. Primary completionOct 2011
  4. Study completionDec 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
2,097 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00741650
Sponsor's protocol ID
801622-611704
Other IDs
18997, S-08054b
Acronym
Ibedrift
Status last verified
Feb 2015
First submitted
25 Aug 2008
Last updated
26 Feb 2015
Results posted
No
Data monitoring committee
No

Publications

  • Odeen M, Ihlebaek C, Indahl A, Wormgoor ME, Lie SA, Eriksen HR. Effect of peer-based low back pain information and reassurance at the workplace on sick leave: a cluster randomized trial. J Occup Rehabil. 2013 Jun;23(2):209-19. doi: 10.1007/s10926-013-9451-z.

    PubMed 23657490
  • Ree E, Odeen M, Eriksen HR, Indahl A, Ihlebaek C, Hetland J, Harris A. Subjective health complaints and self-rated health: are expectancies more important than socioeconomic status and workload? Int J Behav Med. 2014 Jun;21(3):411-20. doi: 10.1007/s12529-013-9329-7.

    PubMed 23868103

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing Information and Peer advisor and Information, peer advisor and fast referral in people with Neck Pain Musculoskeletal and Back Pain Lower Back, run by NORCE Norwegian Research Centre AS at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Feb 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sick Leave (time frame: 1 year and 2 year after start of intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00741650, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Feb 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in